|
 FDA | CDER | Small Business and Industry Assistance
INDUSTRY NEWS
|
|
|
Final:
FDA wants your input to enhance its Rare Disease Drug Development Resources
Are you part of the rare disease drug development community – a developer, researcher, advocate, or innovator? We want to hear from you!
Developing rare disease treatments comes with unique challenges, and so does navigating the rare disease drug development process. By offering educational content, FDA’s Learning and Education to ADvance and Empower Rare Disease Drug Developers (LEADER 3D) initiative helps make rare disease development easier to traverse. Now, we’re looking to enhance LEADER 3D, and your voice can help shape what comes next. Specifically, we'd like to know:
- What aspects of the case studies and educational videos most influenced any changes you might make to your drug development programs?
- Was there any content that you did not easily understand? Did the format of the case studies and videos impact your understanding?
- What other questions or resources should FDA develop educational content around that will help in developing rare disease therapies? Are there formats aside from case studies and videos you would like to see developed?
We encourage you to engage with LEADER 3D through the online platform at the link below. Your feedback will help directly inform LEADER 3D’s future content.
Resources
|
|
|
The Small Business and Industry Assistance (SBIA) program in the Center for Drug Evaluation and Research provides guidance, education and updates for regulated industry.
|
|
|
|
